Autoimmune pulmonary alveolar proteinosis
MONDO:0012579Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the accumulation of a lipoproteinaceous substance in the distal air spaces which positively stains with periodic acid-Schiff (PAS).
Also known as: APAP, Pulmonary Alveolar Proteinosis, autoimmune PAP, iPAP, idiopathic PAP, idiopathic pulmonary alveolar proteinosis, PAP, PAP acquired
41 clinical trials for this condition and its sub-types, 6 tagged with Autoimmune pulmonary alveolar proteinosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Can a daily inhaled protein restore lung function in a rare autoimmune disease?
Disease control OngoingThis trial tests whether inhaling molgramostim—a lab-made version of a protein that helps lung cells clear out protein buildup—can improve lung function in adults with autoimmune pulmonary alveolar proteinosis (aPAP). In this condition, the immune system blocks a key signal, caus…
Phase 3 • Sponsor: Savara Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
AI takes on pap smears: could it match human experts?
Diagnosis By invitation onlyThis study compares a new AI-assisted digital system to the standard manual method for reading Pap tests. About 4,600 cervical cell samples will be reviewed both ways to see if the AI system is just as good at detecting abnormal cells. The goal is to determine if the AI can help …
Sponsor: Techcyte, Inc. • Aim: Diagnosis
Last updated Jun 26, 2026 13:35 UTC